ENDP Executive Compensation
* In USD (Original Currency)
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
---|---|---|---|---|---|---|---|---|
2022-04-28 | 2020 | Patrick Barry Executive Vice President and President, Global Commercial Operations | 540,577 | 739,333 | 0 | 587,664 | 7,592 | 2,691,147 |
2022-04-28 | 2019 | Blaise Coleman President and Chief Executive Officer | 612,115 | 625,000 | 0 | 640,106 | 21,701 | 3,571,648 |
2022-04-28 | 2020 | Blaise Coleman President and Chief Executive Officer | 829,365 | 1,133,333 | 0 | 1,621,800 | 10,839 | 7,169,703 |
2022-04-28 | 2021 | Blaise Coleman President and Chief Executive Officer | 913,461 | 17,504,167 | 0 | 2,506,291 | 7,565 | 28,994,250 |
2022-04-28 | 2021 | Matthew J. Maletta Executive Vice President, Chief Legal Officer and Company Secretary | 666,039 | 5,559,333 | 0 | 767,693 | 29,631 | 9,008,667 |
2022-04-28 | 2020 | Matthew J. Maletta Executive Vice President, Chief Legal Officer and Company Secretary | 665,385 | 816,667 | 0 | 620,100 | 28,048 | 3,513,378 |
2022-04-28 | 2019 | Matthew J. Maletta Executive Vice President, Chief Legal Officer and Company Secretary | 595,192 | 625,000 | 0 | 568,360 | 33,152 | 3,428,636 |
2022-04-28 | 2021 | Patrick Barry Executive Vice President and President, Global Commercial Operations | 583,077 | 4,721,417 | 0 | 829,786 | 12,410 | 7,780,453 |
2022-04-28 | 2019 | Patrick Barry Executive Vice President and President, Global Commercial Operations | 433,885 | 625,000 | 0 | 397,005 | 16,646 | 2,257,805 |
2021-04-29 | 2020 | Domenico Ciarico Former Executive Vice President and Chief Commercial Officer, Sterile and Generics | 407,115 | 345,833 | 0 | 247,757 | 1,500,666 | 3,049,165 |
2021-04-29 | 2020 | Mark Bradley Executive Vice President and Chief Financial Officer | 552,411 | 624,448 | 0 | 583,292 | 11,589 | 2,308,622 |
2021-04-29 | 2020 | George Apostol, M.D. Executive Vice President, Global Research and Development | 352,301 | 29,917 | 0 | 424,709 | 25,086 | 1,007,011 |
2020-04-28 | 2019 | Patrick Barry Executive Vice President and Chief Commercial Officer, U.S. Branded Business | 433,885 | 625,000 | 0 | 397,005 | 16,646 | 2,257,805 |
2019-04-29 | 2016 | Blaise Coleman Executive Vice President and Chief Financial Officer | 349,308 | 100,000 | 0 | 216,563 | 10,819 | 1,157,919 |
2019-04-29 | 2017 | Blaise Coleman Executive Vice President and Chief Financial Officer | 545,833 | 165,000 | 0 | 613,203 | 4,417 | 4,350,511 |
2019-04-29 | 2018 | Blaise Coleman Executive Vice President and Chief Financial Officer | 569,231 | 0 | 0 | 806,188 | 3,385 | 2,635,662 |
2019-04-29 | 2016 | Paul V. Campanelli President and Chief Executive Officer | 987,038 | 0 | 0 | 712,500 | 23,007 | 8,492,910 |
2019-04-29 | 2017 | Paul V. Campanelli President and Chief Executive Officer | 950,000 | 0 | 0 | 1,815,450 | 57,081 | 13,602,395 |
2019-04-29 | 2018 | Paul V. Campanelli President and Chief Executive Officer | 913,462 | 0 | 0 | 2,231,550 | 39,779 | 19,970,703 |
2019-04-29 | 2018 | Terrance J. Coughlin Executive Vice President and Chief Operating Officer | 597,115 | 0 | 0 | 868,672 | 3,692 | 3,129,446 |
2019-04-29 | 2017 | Terrance J. Coughlin Executive Vice President and Chief Operating Officer | 600,000 | 0 | 0 | 800,125 | 5,000 | 5,275,770 |
2019-04-29 | 2016 | Terrance J. Coughlin Executive Vice President and Chief Operating Officer | 556,280 | 0 | 0 | 315,000 | 8,292 | 2,088,991 |
2019-04-29 | 2018 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 549,038 | 0 | 0 | 707,781 | 38,482 | 2,551,127 |
2019-04-29 | 2017 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 543,333 | 0 | 0 | 600,203 | 26,991 | 4,157,334 |
2019-04-29 | 2016 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 504,167 | 0 | 0 | 210,375 | 31,887 | 2,076,793 |
2018-04-27 | 2017 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 543,333 | 0 | 0 | 600,203 | 26,991 | 4,157,334 |
2018-04-27 | 2016 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 504,167 | 0 | 0 | 210,375 | 31,887 | 2,076,793 |
2018-04-27 | 2015 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 322,148 | 0 | 0 | 338,894 | 88,667 | 2,845,571 |
2018-04-27 | 2017 | Tony Pera President, Par Pharmaceutical | 460,000 | 0 | 0 | 409,925 | 39,548 | 2,522,024 |
2017-04-28 | 2016 | Suketu P. Upadhyay Executive Vice President and Chief Financial Officer | 581,555 | 0 | 0 | 0 | 140,998 | 8,128,271 |
2017-04-28 | 2014 | Rajiv De Silva President and Chief Executive Officer | 1,079,167 | 0 | 0 | 2,819,608 | 12,726,292 | 22,071,596 |
2017-04-28 | 2015 | Rajiv De Silva President and Chief Executive Officer | 1,145,833 | 0 | 0 | 1,687,110 | 8,173 | 10,914,725 |
2017-04-28 | 2016 | Rajiv De Silva President and Chief Executive Officer | 840,337 | 0 | 0 | 220,953 | 5,606,505 | 19,176,476 |
2017-04-28 | 2015 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 322,148 | 0 | 0 | 338,894 | 88,667 | 2,845,571 |
2017-04-28 | 2016 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 504,167 | 0 | 0 | 210,375 | 31,887 | 2,076,793 |
2017-04-28 | 2015 | Paul V. Campanelli President and Chief Executive Officer | 272,376 | 0 | 0 | 1,064,000 | 3,977 | 5,954,157 |
2017-04-28 | 2016 | Paul V. Campanelli President and Chief Executive Officer | 987,038 | 0 | 0 | 712,500 | 23,007 | 8,492,910 |
2017-04-28 | 2016 | Brian Lortie President, U.S. Branded Pharmaceuticals | 363,250 | 0 | 0 | 42,225 | 1,642,829 | 3,046,030 |
2017-04-28 | 2016 | Hemanth J. Varghese President, International Pharmaceuticals and Executive Vice President of Corporate Development | 544,333 | 0 | 0 | 264,825 | 2,781,998 | 5,698,662 |
2017-04-28 | 2014 | Suketu P. Upadhyay Executive Vice President and Chief Financial Officer | 595,833 | 240,000 | 0 | 708,840 | 2,182,270 | 5,599,641 |
2017-04-28 | 2015 | Suketu P. Upadhyay Executive Vice President and Chief Financial Officer | 625,000 | 0 | 0 | 486,936 | 221,547 | 4,489,781 |
2017-04-28 | 2016 | Terrance J. Coughlin Executive Vice President and Chief Operating Officer | 556,280 | 0 | 0 | 315,000 | 8,292 | 2,088,991 |
2017-04-28 | 2016 | Joseph J. Ciaffoni President, U.S. Branded Pharmaceuticals | 217,837 | 250,000 | 0 | 207,000 | 1,944,150 | 5,022,567 |
2017-04-28 | 2016 | Blaise Coleman Executive Vice President and Chief Financial Officer | 349,308 | 100,000 | 0 | 216,563 | 10,819 | 1,157,919 |
2016-04-28 | 2015 | Paul V. Campanelli President, Par Pharmaceutical | 272,376 | 0 | 0 | 1,064,000 | 3,977 | 5,954,157 |
2016-04-28 | 2015 | Matthew J. Maletta Executive Vice President, Chief Legal Officer | 322,148 | 0 | 0 | 338,894 | 88,667 | 2,845,571 |
2016-04-28 | 2015 | Susan Hall, Executive Vice President, Chief Scientific Officer and Global Head of Research & Development and Quality | 512,500 | 0 | 0 | 398,051 | 169,775 | 2,120,717 |
2015-04-29 | 2013 | Camille I. Farhat President, American Medical Systems | 528,846 | 0 | 0 | 542,438 | 73,893 | 2,037,853 |
2015-04-29 | 2014 | Caroline B. Manogue Executive Vice President & Chief Legal Officer | 576,167 | 0 | 0 | 547,224 | 11,045,267 | 13,835,574 |
2015-04-29 | 2013 | Caroline B. Manogue Executive Vice President & Chief Legal Officer | 562,000 | 0 | 0 | 567,786 | 69,521 | 2,839,661 |
2015-04-29 | 2012 | Caroline B. Manogue Executive Vice President & Chief Legal Officer | 558,333 | 0 | 0 | 0 | 93,629 | 2,008,632 |
2015-04-29 | 2014 | Camille I. Farhat President, American Medical Systems | 567,769 | 0 | 0 | 500,797 | 4,007,230 | 6,963,720 |
2015-04-29 | 2012 | Camille I. Farhat President, American Medical Systems | 179,315 | 0 | 0 | 110,000 | 205,215 | 838,020 |
2014-04-29 | 2013 | Donald DeGolyer Chief Operating Officer, Pharmaceuticals | 270,833 | 0 | 0 | 524,940 | 344,154 | 3,783,194 |
2014-04-29 | 2013 | Rajiv De Silva President and Chief Executive Officer | 771,875 | 3,500,000 | 0 | 2,193,750 | 92,256 | 12,594,052 |
2014-04-29 | 2013 | Suketu P. Upadhyay Executive Vice President & Chief Financial Officer | 157,019 | 0 | 0 | 186,006 | 226,557 | 2,165,499 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.